BG60208B2 - Process for preparingn-substituted 3-acyl-2-oxindole-1-carboxamides - Google Patents

Process for preparingn-substituted 3-acyl-2-oxindole-1-carboxamides

Info

Publication number
BG60208B2
BG60208B2 BG70071A BG7007185A BG60208B2 BG 60208 B2 BG60208 B2 BG 60208B2 BG 70071 A BG70071 A BG 70071A BG 7007185 A BG7007185 A BG 7007185A BG 60208 B2 BG60208 B2 BG 60208B2
Authority
BG
Bulgaria
Prior art keywords
preparingn
oxindole
carboxamides
acyl
substituted
Prior art date
Application number
BG70071A
Inventor
Saul B Kadin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BG60208B2 publication Critical patent/BG60208B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Abstract

The obtained compounds are used as analgetic and anti-inflammatory agents. According to the method, a compound of the formula wherein X is on the fifth or sixth place and means hydrogen, fluorine, chlorine or trifluoromethyl, Y is hydrogen, and R2 is alkyl having 2 to 4 hydrogen atoms, cyclohexyl, benzyl, phenyl, fluorophenyl, 2,4 - difluorophenyl, chlorophenyl or methoxyphenyl reacts with an activated derivative of the carboxylic acid in an inert solvent in the presence of alkaline agent.
BG70071A 1984-05-04 1985-05-03 Process for preparingn-substituted 3-acyl-2-oxindole-1-carboxamides BG60208B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60735684A 1984-05-04 1984-05-04

Publications (1)

Publication Number Publication Date
BG60208B2 true BG60208B2 (en) 1993-12-30

Family

ID=24431933

Family Applications (2)

Application Number Title Priority Date Filing Date
BG70071A BG60208B2 (en) 1984-05-04 1985-05-03 Process for preparingn-substituted 3-acyl-2-oxindole-1-carboxamides
BG96583A BG60207B2 (en) 1984-05-04 1992-07-08 Process for preparing n-substituted 3-acyl-2-oxindole-1-carboxamides

Family Applications After (1)

Application Number Title Priority Date Filing Date
BG96583A BG60207B2 (en) 1984-05-04 1992-07-08 Process for preparing n-substituted 3-acyl-2-oxindole-1-carboxamides

Country Status (25)

Country Link
JP (1) JPS60243068A (en)
KR (1) KR870000497B1 (en)
AR (1) AR241159A1 (en)
BG (2) BG60208B2 (en)
CS (1) CS252828B2 (en)
DD (1) DD232916A5 (en)
EG (1) EG17193A (en)
ES (2) ES8609248A1 (en)
FI (1) FI80016C (en)
HU (1) HU196057B (en)
IE (1) IE851103L (en)
IN (1) IN161509B (en)
MA (1) MA20424A1 (en)
MW (1) MW1685A1 (en)
MX (1) MX5839A (en)
NO (1) NO163132C (en)
OA (1) OA08098A (en)
PL (2) PL145416B1 (en)
PT (1) PT80375B (en)
RO (2) RO94455B (en)
RU (1) RU2017729C1 (en)
SU (1) SU1468413A3 (en)
YU (1) YU44998B (en)
ZA (1) ZA853324B (en)
ZW (1) ZW7885A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
IL95880A (en) * 1989-10-13 1995-12-31 Pfizer Use of 3-substituted-2-oxindole derivatives for the preparation of a pharmaceutical preparation for inhibiting interleukin-1 biosynthesis

Also Published As

Publication number Publication date
RO94455A (en) 1988-06-30
ES542813A0 (en) 1986-07-16
RU2017729C1 (en) 1994-08-15
YU73085A (en) 1988-04-30
PL145416B1 (en) 1988-09-30
PT80375B (en) 1987-09-30
FI80016B (en) 1989-12-29
CS252828B2 (en) 1987-10-15
FI80016C (en) 1990-04-10
CS320285A2 (en) 1987-03-12
HUT37754A (en) 1986-02-28
AR241159A1 (en) 1991-12-30
PL257892A1 (en) 1986-10-07
MA20424A1 (en) 1985-12-31
AR241159A2 (en) 1991-12-30
NO851774L (en) 1985-11-05
NO163132C (en) 1990-04-11
ES8609248A1 (en) 1986-07-16
IN161509B (en) 1987-12-19
SU1468413A3 (en) 1989-03-23
PL253203A1 (en) 1986-06-17
YU44998B (en) 1991-06-30
DD232916A5 (en) 1986-02-12
ZA853324B (en) 1986-12-30
HU196057B (en) 1988-09-28
MW1685A1 (en) 1986-09-10
RO91141A (en) 1987-06-30
ES8707182A1 (en) 1987-07-16
OA08098A (en) 1987-03-31
IE851103L (en) 1985-11-04
KR870000497B1 (en) 1987-03-12
MX5839A (en) 1993-11-01
RO94455B (en) 1988-07-01
NO163132B (en) 1990-01-02
RO91141B (en) 1987-07-03
PT80375A (en) 1985-05-01
KR850008154A (en) 1985-12-13
EG17193A (en) 1990-08-30
BG60207B2 (en) 1993-12-30
FI851756L (en) 1985-11-05
ZW7885A1 (en) 1985-07-24
JPH0335315B2 (en) 1991-05-27
PL147508B1 (en) 1989-06-30
ES551275A0 (en) 1987-07-16
FI851756A0 (en) 1985-05-03
JPS60243068A (en) 1985-12-03

Similar Documents

Publication Publication Date Title
ES483700A1 (en) Antiinflammatory 4,5-diaryl-2-nitroimidazoles, method for their preparation and pharmaceutical composition containing them.
ES2005745A6 (en) Process for the preparation of aryl-piperidine carbinols.
AU577362B2 (en) Alpha-halo-ketals and preparation of optically active alpha-arylalkanoic acids
ES8706664A1 (en) Carbostyril compounds, compositions containing same and processes for preparing same.
TW232013B (en)
AU600897B2 (en) N-acyl-alpha-amino-alpha-hydroxy acetic acid ester
NZ318843A (en) Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine
ES449096A1 (en) 11-Desoxy-16-aryloxy-{107 -tetranorprostaglandins
AU1395283A (en) 1-carboxyalkanoylindoline-2-carboxylic acid esters
ES8700242A1 (en) Chemical compounds.
AU578169B2 (en) N-alkylation of dihydrolysergic acid
BG60208B2 (en) Process for preparingn-substituted 3-acyl-2-oxindole-1-carboxamides
MY131544A (en) Fluorinated 4-aminoandrostadienone derivatives and process for their preparation
ES2016017A6 (en) 1,1-dioxo-cephem-4-carbothiolic acid derivatives.
ES477878A1 (en) Mercaptoacylamino acids
GEP20033119B (en) Novel Octahydro-6, 10-Dioxo-6H-Pyridazino {1,2-a}{1 Carboxylic Acid Derivatives, Method for Preparation and Use Thereof
ES8304971A1 (en) Process for the preparation of azabicyclo(3.2.0)-hept-2-ene derivatives.
NO924617L (en) PROCEDURE FOR PREPARING 10BETA-H STEROIDS
EP0074130A3 (en) New imidazole compounds, process for the preparation thereof and pharmaceutical compositions containing them
ES475189A1 (en) Alpha-isocyanocarboxylic acid salts, method for their preparation, and their use as plant growth controlling agents.
DE3462031D1 (en) Alpha,alpha-dimethylphenylacetanilide derivatives, process for production thereof, and use thereof as insecticide
NZ233196A (en) Process for preparing glutaric acid derivatives and 2-alkoxycarbonylalkyl cyclohexanone derivatives
IT1207255B (en) 1,2,4-TRIAZOLIC DERIVATIVES, A PROCEDURE FOR THEIR PRODUCTION, THEIR USE AS ANTI-REPRODUCTIVE AGENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
JPS56130478A (en) Composition for preventing metal corrosion
JPS5592363A (en) New 2-azetidinone derivative